Skip to main content
. 2023 Feb 16;2023:3077180. doi: 10.1155/2023/3077180

Table 1.

Basic demographic data of patients.

Demographic indicators NMHR (n = 93) MHR (n = 54) P
Age (years) 57.0 (49.0, 63.5) 52.5 (48.0, 57.0) 0.009
Whether menopause No 49 (52.7) 33 (61.1) 0.322
Yes 44 (47.3) 21 (38.9)

History of birth and lactation No 6 (6.5) 0 (0.0) 0.141
Yes 87 (93.5) 54 (100.0)

Family history No 91 (97.8) 54 (100.0) 0.278
Yes 2 (2.2) 0 (0.0)

Lymph node metastasis No 22 (23.9) 14 (25.9) 0.785
Yes 70 (76.1) 40 (74.1)

Period of treatment <6 issues 39 (41.9) 12(22.2) 0.015
≥6 periods 54 (58.1) 42 (77.8)

Program TAC 47 (50.5) 20 (37.0) <0.001
TCbHP 2 (2.2) 13 (24.1)
AT 11 (11.8) 8 (14.8)
TP 4 (4.3) 5 (9.3)
AC 8 (8.6) 1 (1.9)
TC 21 (22.6) 7 (13.0)

Pathological type Catheter 80 (86.0) 45 (83.3) 0.728
Leaflet 6 (6.5) 3 (5.6)
Myeloid 4 (4.3) 2 (3.7)
Unknown 3 (3.2) 4 (7.4)

ER Feminine 32 (35.2) 39 (75.0) <0.001
Positive 59 (64.8) 13 (25.0)

PR Feminine 51 (56.0) 46 (88.5) <0.001
Positive 40 (44.0) 6 (11.5)

CerbB-2 Feminine 7 (7.6) 3 (5.6) 0.893
Positive 85 (92.4) 51 (94.4)

Ki67 Feminine 20 (22.2) 3 (5.8) 0.010
Positive 70 (77.8) 49 (94.2)